New Zealand Passes Milestone E-cigarette Legislation

Oct.27.2022
New Zealand Passes Milestone E-cigarette Legislation
New Zealand's landmark e-cigarette legislation bans sales to under 18s and restricts use in public spaces.

On November 11, 2020, the "2020 Smokefree Environments and Regulated Products (Vaping) Amendment Act" came into effect in New Zealand. Two years later, New Zealand passed a landmark vaping legislation.


New Zealand's legislation and regulations may not be perfect, but they continue to set an example for other countries eager to combat tobacco. It's not the time to throw the baby out with the bathwater," said Nancy Lucas, co-founder of the New Zealand Vaping Advocacy Alliance.


The bill aims to ensure that smokers who want to switch to safer alternatives can use e-cigarette products and also ensure that these products are not sold or distributed to minors. It seeks to strike a balance between promoting the use of e-cigarettes for harm reduction and preventing their use among young people.


Ms. Lucas stated that while New Zealand continues to implement various industry regulations, the requirements that went into immediate effect two years ago have had a positive impact.


Starting from November 11th, 2020, the use of electronic cigarettes is prohibited in workplaces, schools, childcare centers, and other locations. Sales of electronic cigarette products to individuals under the age of 18, as well as all advertising and sponsorships related to electronic cigarette products, are also prohibited. "If youth e-cigarette use is a problem, the solution isn't changing the law, because it's already abundant. The solution lies in parental responsibility and greater enforcement by regulatory agencies. Those found selling e-cigarettes to minors may face severe penalties. Any rogue retailer now has to face the consequences, as they make good legislation look bad," Ms. Lucas said.


The New Zealand E-Cigarette Advocacy Group has stated that the title of the Ministry of Health's website on e-cigarettes being "less harmful than smoking" is also world-leading.


New Zealand is currently engaged in a public battle to achieve a smoke-free status by 2025, which would mean reducing smoking rates to 5% or below. In comparison, Australia's ban on selling safer nicotine products and scaremongering tactics with publicly-funded campaigns have had little impact in reducing smoking rates in recent years, according to a spokesperson. In order to further curb the appeal and availability of deadly tobacco, the Health Select Committee will deliver a report on amendments to create smoke-free environments and regulated products, including traditional tobacco, by December 1st.


Ms. Lucas stated that now is the time for a strict crackdown on tobacco, rather than re-prosecuting the electronic cigarette rules and regulations that were fiercely debated and scrutinized by parliament and health leaders. "Governments, politicians, and officials from around the world continue to study the work that New Zealand has done in reducing smoking rates and achieving a smoke-free goal. Maintaining its harm reduction approach to tobacco is how New Zealand will suppress tobacco and save thousands of lives each year," said Nancy Lucas.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's contents. The compilation of this article is intended solely for industry exchange and research.


Due to limitations in translation proficiency, the translated article may not fully express the content of the original piece. Please refer to the original article for accuracy.


2FIRSTS is in complete alignment with the Chinese government when it comes to any domestic, Hong Kong, Macau and Taiwan-related, or foreign positions and expressions.


The copyright of the compiled information belongs to the original media and author. If there is infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York State will extend its tobacco products tax to “alternative nicotine products,” including tobacco-free nicotine pouches, from September 1, 2026, at a rate of 75% of the wholesale price. Distributors, wholesalers and retailers must also inventory products held as of 11:59 p.m. on August 31 and pay a floor tax. Vapor products are excluded from the new category and remain subject to New York's separate 20% supplemental sales tax on the retail price.
Aug.26
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives